Ovarian Granulosa-Stromal Tumor clinical trials at UCLA

1 in progress, 0 open to eligible people

Nirogacestat in Ovarian Granulosa Cell Tumors
Sorry, in progress, not accepting new patients
This phase 2 clinical trial will study the effectiveness of nirogacestat in ovarian granulosa cell tumors (OvGCTs). Nirogacestat is a gamma secretase inhibitor (GSI) which is hypothesized to decrease the growth and activity of ovarian granulosa tumors.
Los Angeles, California and other locations

Last updated: August 2024